University Diabetes and Endocrine Consultants

Chattanooga, Tennessee 37411

1 studies enrolling now · 13 studies all time

What they study most

Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes type1, Diabetic Kidney Disease, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Type2 Diabetes

Studies at this site

• GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes — Recruiting now
• OP5-005 Using Omnipod 5 in Adults With Type 2 — Completed
• Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients — Completed
• Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles — Completed
• A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D) — Completed
• Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease — Completed
• An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus — Completed
• A Study of LY900014 in Participants With Type 1 Diabetes — Completed
• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
• A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus — Stopped early
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed
• A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus — Completed
• Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin — Completed